The effects of hormone therapy on bone mass density in amenorrhea/oligomenorrhea female athletes
Not Applicable
- Conditions
- Amenorrhea/Oligomenorrhea.Absent, scanty and rare menstruation
- Registration Number
- IRCT138904024251N1
- Lead Sponsor
- Research committee of Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Iranian elite female athletes, presence of amenorrhea/oligomenorrhea
Exclusion criteria: regular menstruation pattern before beginning of the study, cessation of exercise, using hormonal medication, calcium supplement, or thyroid hormone
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Menstrual pattern among athletes. Timepoint: Every month for nine months. Method of measurement: through coming to clinic or phone or fax or email for athletes who do not live in Tehran.;Bone mineral density. Timepoint: Baseline and after nine months. Method of measurement: Bone Densitometry maschine (HOLOGIC).
- Secondary Outcome Measures
Name Time Method Weight. Timepoint: Baseline and after nine monthsafter. Method of measurement: in kilograms by Balance.;Heart Rate and Blood pressure in supune position. Timepoint: Baseline and after nine monthsafter. Method of measurement: stethoscope and Blood pressure cuff.;Waist circumference. Timepoint: Baseline and after nine monthsafter. Method of measurement: in centimeters by Tape.;Height. Timepoint: Baseline and after nine monthsafter. Method of measurement: in centimeters by Tape.;Lipid profile include (Total cholestrol (LDL, HDL), TG, Apo a and Apo b). Timepoint: Baseline and after nine monthsafter. Method of measurement: Blood sample.;Cardiovascular factors (hemocystein and Fibrinogen). Timepoint: Baseline and after nine monthsafter. Method of measurement: Blood sample.